BEN vs ASND Comparison

Franklin Resources provides investment services for individual and institutional investors. At the end of December 2025, Franklin had $1.684 trillion in managed assets, composed primarily of equity (41%), fixed-income (26%), multi-asset/balanced (12%) funds, alternatives (16%), and money market funds (5%). Distribution tends to be weighted between retail investors (57% of AUM) and institutional accounts (40%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 30% of its assets under management invested in global/international strategies and 29% sourced from clients domiciled outside the United States.

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.